Abstract
To evaluate the clinical significance of serum levels of hepatocyte growth factor (HGF) in colorectal cancer patients, we measured the venous and portal concentrations of HGF in 60 patients. The tissue concentrations in the tumour and adjacent normal mucosa were also determined. The serum HGF concentration for the peripheral venous blood of the patients was significantly higher than that in normal controls. The content of HGF in cancer tissue was also significantly higher than that in normal mucosa, and it was correlated with the serum HGF concentration for the peripheral venous blood. The serum concentration of HGF reflected pathological features, including tumour size and lymph node or liver metastasis, and it showed an association with various preoperative nutritional parameters and the preoperative haemoglobin level. The serum HGF concentration was also correlated with the serum concentrations of immunosuppressive acidic protein and interleukin-6, indices of the host's immunological condition. Serum HGF seems to be a useful index of the disease status of patients with colorectal carcinoma.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fukuura, T., Miki, C., Inoue, T. et al. Serum hepatocyte growth factor as an index of disease status of patients with colorectal carcinoma. Br J Cancer 78, 454–459 (1998). https://doi.org/10.1038/bjc.1998.514
Issue Date:
DOI: https://doi.org/10.1038/bjc.1998.514
This article is cited by
-
A receptor-antibody hybrid hampering MET-driven metastatic spread
Journal of Experimental & Clinical Cancer Research (2021)
-
Screening of Hub Genes and Pathways in Colorectal Cancer with Microarray Technology
Pathology & Oncology Research (2014)
-
Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis
Apoptosis (2013)
-
Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients
British Journal of Cancer (2008)
-
Combined Measurement of Hepatocyte Growth Factor and Carcinoembryonic Antigen as a Prognostic Marker for Patients with Dukes A and B Colorectal Cancer: Results of a Five-Year Study
Diseases of the Colon & Rectum (2006)